Science 7 - LAND and SEA BREEZE and its Characteristics
Ā
What stars can teach us about cancer: Modeling metastasis through population genetics
1. What the study of the stars can teach us about cancer:
Thereās no success like failure, and failureās no success at all.
Jacob G. Scott
Key Factors in the Metas
from Populatio
Christopher McFarland1*, Jacob Scott2,3,*, David Bas
1Harvard-MIT Division of Health Science & Technology, 2H. Lee Moffitt
Oncology, *contributed equally to this workoorly understood process that
aths
not explained by deterministic
the genomic level and use
explore this phenomenon
Res
Cells deriv
Metastatic
Three regi
metastasis
which only
We further
Feature of Model Observed Phenomenon
Population size determined
by fitness of cells
Larger Tumors more likely to
metastasize
Cells can acquire passenger
mutations that are slightly
deleterious
Many micrometastases never
grown to macroscopic size
Cells with more mutations are
less likely to metastasize
Stromal environment reduces
efficacy of driver mutations
Certain stromal conditions
prohibit metastasis
Metastases with same
Key Factors in the Meta
from Populat
Christopher McFarland1*, Jacob Scott2,3,*, David B
1Harvard-MIT Division of Health Science & Technology, 2H. Lee Mo
Oncology, *contributed equally to this work
Background:
Metastasis is a highly lethal and poorly understood process that
accounts for the majority cancer deaths
Patterns of metastatic spread are not explained by deterministic
explain these patterns
We develop a stochastic model at the genomic level and use
population genetics techniques to explore this phenomenon
R
Cells
Meta
Three
metas
which
We fu
Feature of Model Observed Phenomenon
Population size determined
by fitness of cells
Larger Tumors more likely to
metastasize
Cells can acquire passenger
mutations that are slightly
deleterious
Many micrometastases never
grown to macroscopic size
Cells with more mutations are
less likely to metastasize
Stromal environment reduces
efficacy of driver mutations
Certain stromal conditions
prohibit metastasis
Radiation Oncology and
Integrative Mathematical
Oncology
further, the stem compartment can diļ¬erentiate at a rate Ī². Each population als
growth (r) and death (d) rate, proportional to their population.
FIG. 3: To capture the behavior of a putative compartment system in which there is only e
from the stem compartment into the TAC compartment, death and growth in both, but
by a common carrying capacity.
We therefore write a system of ODEs as:
Stem compartment :
dN0
dt
=
growth
r0N0(1 ā
N
K
) ā
diļ¬erentiation
Ī²0N0 ā
death
d0N0
Diļ¬erentiated :
dN1
dt
=
growth
r1N1(1 ā
N
K
) +
diļ¬erentiation
Ī²0N0 ā
death
d1N1
Where:
Phys. Biol. 8 (2011) 015016 D Basanta et al
Table 1. The four phenotypes in the game are autonomous growth
(AG), invasive (INV), glycolytic (GLY) and invasive glycolytic
(INV-GLY). The base payoff in a given interaction is r and the cost
of moving to another location with respect to the base payoff is c.
The ļ¬tness cost of acidity is n and k is the ļ¬tness cost of having a
less efļ¬cient glycolytic metabolism. The beneļ¬ts from having
access to the vasculature as a result of angiogenesis are reļ¬ected by
the parameter Ī±.
AG INV GLY INV-GLY
AG 1
2
+ Ī±
2
1 1
2
ā n + Ī± 1
2
ā n + Ī±
INV 1 ā c 1 ā c
2
1 ā c
3
1 ā c
3
GLY 1
2
ā k + n + Ī± 1 ā k + Ī±
2
1
2
ā k + Ī±
4
1 ā k + Ī±
2
INV-GLY 1
2
ā k + n + Ī± 1 ā k + Ī±
2
1 ā c
3
ā k + Ī±
2
1 ā k ā c
6
+ Ī±
2
Table 2. List of variables used by the model.
Value Affected phenotypes Meaning
c INV, INV-GLY Cost of motility
k GLY, INV-GLY Cost having a glycolytic metabolism
n AG, INV Cost of living in an acid
microenvironment
to leaky or otherwise defective vascularization [9]. This is
shown in the table by the fact that AG cells interacting with
other AG cells (assumed to produce only moderate amounts of
HIF-1Ī±) receive a beneļ¬t of Ī±
2
from the moderate angiogenic
vasculature. On the other hand, AG cells interacting with
GLY cells produce, in combination, an optimal amount of
HIF-1Ī± and obtain in return the total beneļ¬t derived from
functioning vascularity (Ī±). Finally, as IDH-1 mutant GLY
cells proliferate producing excessive amounts of HIF-1Ī±, the
beneļ¬t of angiogenesis is a reduced Ī±
4
, consistent with the
angiogenic vasculature being leaky and inefļ¬cient in this case.
Another notable difference with the previous model is that
the cost of motility is assumed to be smaller in the presence of
acid-producing glycolytic phenotypes. This is represented by
a cost of motility c
3
and represents the acid-mediated invasion
[21ā23] of glioma cells throughout the brain, particularly along
the myelinated neuronal axons in the white matter of the brain
along which glioma cells are known to quickly invade [24, 25].
This reduced cost of motility also quantiļ¬es and models the
generally invasive characteristics of gliomas which are well
known for their diffuse invasion that has been quantiļ¬ed in
In one dimension, this becomes:
ā
āx
ļ£®
ļ£Æ
ļ£°D
āc
āx
+ Ļc
āa
āx
ļ£¹
ļ£ŗ
ļ£» = Dc
ā2
c
āx2
ā cĻ(a)
ā2
a
āx2
ā Ļ
āc
āx
āa
āx
(2.18)
Additionally, we must consider the creation and dispersal of this chemoattractant, a. To do this, we assume
Fickian diļ¬usion as for the cells in the initial model as per 2.8, and a creation term that is linearly related
to the death of the cells by a coeļ¬cient, Ļ. Further, we introduce a consumption term, the rate at which
the chemoattractant is consumed by the cells, linearly related to the number of cells by a coeļ¬cient, Āµ.
Therefore, we can write down a full model for both the cellular concentration, as derived above, and for the
chemoattractant, a, thus:
rate of change of
glioma cell concentration
āc
āt
=
net dispersal
of glioma cells
ā Ā· (Dcāc) +
net growth
of glioma cells
Ļc(1 ā
c
K
) ā
chemotaxis
of glioma cells
ā Ā· (cĻ(a)āa) ā
death
of glioma cells
Ī»c , (2.19)
rate of change of
chemotactic factor
āa
āt
=
net dispersal of
chemotactic factor
ā Ā· (Daāa) +
creation of
chemotactic factor
Ī»cĻ ā
consumption of
chemotactic factor
Āµca . (2.20)
And again in 1-dimension:
āc
āt
= D
ā2
c
āx2
ā cĻ(a)
ā2
a
āx2
ā Ļ
āc
āx
āa
āx
+ c(1 ā
c
Kc
) ā Ī»c, (2.21)
āa
āt
= Da
ā2
a
āx2
+ Ī»cĻa ā Āµca. (2.22)
While the death term has remained a constant, Ī», times the population, this addition does little to eļ¬ect the
overall dynamics. Only with very large parameter changes, likely large enough to be physically unrealistic,
?
2. Tortuous Path
ā¢Hawken ā94
ā¢US Naval Academy ā98, Physics
Major
ā¢Navy Nuclear Reactor Engineer
ā98-ā03
ā¢High School Physics Teacher
Florida, ā03-ā04
ā¢Case Western Reserve MD
2004-2009
ā¢Radiation Oncology Resident
Tampa, FL, ā09-Present
ā¢Oxford D.Phil candidate -
mathematics
8. Important to understand your limitations:
Dogs are so cute when they
try to comprehend quantum
mechanics - Iām not.
As Mr. Dlugozs will tell
you, I am a terrible bench
biologist - yes, I tried.
16. suggest we all adopt ideologies such side of the majority, but to escape j.stebbing
Essay
Phase itrialist
There is a new breed of clinical trialist
in cancer research. You might not
have seen them yetāthey will not
be knocking down your door in the
clinic. They do not know what HIPAA
stands for. They do not know what
to do in a code. They do not wear a
white coat, you will be lucky if they
wear a tie. They are not biologistsāif
you ask them to change the media,
they will probably bring you some
music you have not heard. They are
the phase i trialists.
What is a phase i trial? It is a
preclinical trial, but one in which no
cells, mice, or rats will be harmed.
Before one begins killing cells in
a dish, there is the step to decide
how to treat those cells or mice in
a sensible, yet new way. It is in this
phase, before even stepping into
a laboratory, in which we are now
seeing an inļ¬ux of other types of
scientistsāphysicists, engineers, and
mathematicians. Some of these folks
have run out of problems in their
ļ¬eld and have found fertile ground
for their tools and physical science
perspective in the dizzying biological
complexity of cancer. Others have
become frustrated by the esoteric
nature of their ļ¬rst specialtyāit takes
a special mind to be happy studying
things in other galaxies, or things so
small that you need a super collider
spanning three countries to learn
anything new.
And then, some are just naturally
dreamers, or follow their hearts into
a specialty that has aļ¬ected their
you turn
research
as app
to gene
energy
people w
be expla
we can b
or a com
how a tu
how a pe
phase i.
The bi
right no
and scie
with a
to bet
grant m
mathem
to think
they too
until the
from th
Cancer and Society
From experience, we believe that
doctors are far less accepting of such
ideas than patients or healthy non-
physicians. Oncologists are more
tolerant of the concept of ginger as a
treatment for chemotherapy-induced
nausea becausethese data come from
a large trial with sound statistical
analysis. However, its potential as an
anticancer drug directly conļ¬icts with
the beliefs of most physicians, even
though no precise mechanism of
action has been conļ¬rmed for either
potential use. We certainly do not
suggest we all adopt ideologies such
as those advocated by the authors
of books such as How to Cure Almost
Any Cancer at Home for $5Ā·15 a Day,
but perhaps many of us are guilty of
intolerance of alternative therapeutic
ideologies.
Albert Einstein is quoted as saying
that insanity was ādoing the same
thing over and over again and
expecting a diļ¬erent resultā, and
perhaps some cancer researchers
are guilty of this way of thinking.
Marcus Aurelius once said āthe
object of life is not to be on the
side of the majority, but to escape
ļ¬nding o
insaneā.
that if m
researche
philosoph
professio
worth of
ginger m
doctors m
idea of th
concentr
Jonathan
Imperial Co
j.stebbing@
Essay
Phase itrialist
There is a new breed of clinical trialist
in cancer research. You might not
have seen them yetāthey will not
be knocking down your door in the
clinic. They do not know what HIPAA
stands for. They do not know what
to do in a code. They do not wear a
a dish, there is the step to decide
how to treat those cells or mice in
a sensible, yet new way. It is in this
phase, before even stepping into
a laboratory, in which we are now
seeing an inļ¬ux of other types of
scientistsāphysicists, engineers, and
you turn
research?
as appl
to genet
energy t
people w
be explai
17. Molecular
Reductionism
Qolism
Cellular Organism
the current i
which invasi
cancer progr
There are
these hypoth
relevant to th
First, this is a
mathematica
cancer resear
type of insigh
perhaps mos
such quantit
used. Second
to experimen
conceived. In
experiments
conducted in
relevance of
quantitative
cult and the
it exposes a g
cal and expe
Figure 2 | Cancer is multiscale. Changes at the genetic level lead to modified intracellular signal-
lingwhichcauseschangesincellularbehaviourandgivesrisetocanceroustissue.Eventually,organs
and the entire organism are affected. We propose that a focus on the cell as the fundamental unit
PERSPECTIVES
~10-20 - 1020 meters
18. Each of these models explains only a small part of our
experience on this earth - and with caveats...
But can we just
add them all up
and recapitulate
life?
19. Mechanistic Modeling:
but at what scale?
Bioinformatics
498 I. J. Radiation Oncology d Biology d Physics Volume 75, Number 2, 2009
20. Build models!
What is Science?
What do Scientists do?
āAll models are wrong, but some are usefulā
George E P Box (Statistician)
21. Nutrients (c)
Signalling
Proteases (m)
Invasive front
Angiogenesis
Stem cell
Inflammatory response
Stromal cell
Immune cell
Normal cell
Matrix adhesion
Dm
2
m ni,j ā m,
m
t
ā m ,
t
Dc
2m ā ni,jc ā c.
c
t
Tumour cells (n)
Extracellular matrix (f)
plement
ch as
M)
s and
ge over
by a set of
es a
of cancer
n intuitive
ancer
tion.
behav-
nt?Each
riven by
quantified
escribes
ucially,
lattice
s context
fficients
We can
PERSPECTIVES
22. Cancer is not only a collection of mutated cells
A complex system of many interacting cellular and
microenvironmental elements that were once normal
23. ā¢More complex models are better
ā¢Something that looks similar is similar
ā¢Biological facts should drive derivation
ā¢Distill key components (Dialogue)
ā¢Focus on mechanism
ā¢Subsequent model refinementāAll models are wrong, but some are usefulā
George E P Box (Statistician)
āModels should be simple but no simplerā
Albert Einstein
Minimal modeling approach
24. We use a suite of mathematical and computational
models to bridge a range of spatial and temporal scales.
TIME/SPATIAL SCALE
CELLULAR DETAIL
Evolutionary
Game Theory
Reaction
Diffusion Models
Hybrid Cellular
Automata
Cellular Potts
Model
Immersed
Boundary Model
Hybrid Cellular
Automata
Non-spatial
continuum
Reaction
Diffusion
Network
Theory
30. Cons
Over simplification (no cycle)
Proliferate with same rate at same time
Non-spatial
No mechanistic insight
Pros
Fit tumour growth data well
Compartmental models
Time
CellDensity
31. We use a suite of mathematical and computational
models to bridge a range of spatial and temporal scales.
TIME/SPATIAL SCALE
CELLULAR DETAIL
Evolutionary
Game Theory
Reaction
Diffusion Models
Hybrid Cellular
Automata
Cellular Potts
Model
Immersed
Boundary Model
Hybrid Cellular
Automata
Non-spatial
continuum
Reaction
Diffusion
Network
Theory
32. āN(x,t)
āt
= D
ā2
N(x,t)
āx2
N, number of cells at
time t, position x
D, Diffusion coefficient
the rate of change of cell
number at position x and time t =
change in cell number
due to random dispersal
33. dN(x,t)
dt
= D
ā2
N(x,t)
āx2
+ Ī»N(x,t) 1ā
N(x,t)
K
āļ£«
āļ£āļ£¬
āļ£¶
ā ļ£øāļ£·
Sir Ronald Fisher
1890-1962
N, number of cells at time
t, position x
D, Diffusion coefficient
Ī», proliferation rate
K, carrying cpacity
the rate of change of cell
number at position x and
time t
=
change in cell number
due to random dispersal + change in cell number
due to cell proliferation
34. du
dt
= Du
ā2
u
āx2
ā Ļv,
dv
dt
= Dv
ā2
v
āx2
ā u ā v
Alan Turing
1912-1954
u, activator
v, inhibitor
D, Diffusion coefficients
, proliferation rateĻ
35. We use a suite of mathematical and computational
models to bridge a range of spatial and temporal scales.
TIME/SPATIAL SCALE
CELLULAR DETAIL
Evolutionary
Game Theory
Reaction
Diffusion Models
Hybrid Cellular
Automata
Cellular Potts
Model
Immersed
Boundary Model
Hybrid Cellular
Automata
Non-spatial
continuum
Reaction
Diffusion
Network
Theory
37. LETTER TO THE EDITOR
Production of 2-hydroxyglutarate by
isocitrate dehydrogenase 1āmutated
gliomas: an evolutionary alternative
to the Warburg shift?
Neuro-Oncology
Neuro-Oncology Advanc
Neuro-Oncology
NEURO-ONCOLOGY
Neuro-Oncology Advance Access published July 22, 2011
015016 D Basanta et al
Invasion
BeforeBevacizumabAfterBevacizumab
Loss of PET signal
~ Less Glycolysis
starting
t t t
reduce
0 200 400 600 800 1000
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 200 400 600 800 1000
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 200 400 600 800 1000
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
Figure 3. Plot of k = 0.1, n = 0.2, c = 0.1 and Ī± = 0.3, 0.32, 0.35. The ļ¬rst panel shows two interesting dynamics: with increasing beneļ¬
vasculature (increasing Ī±), we see a more rapid progression as well as a higher overall proportion of cells with the GLY phenotype. Also
decreasing Ī± promotes the INV phenotype (stars) which is recapitulated in recurrent glioblastoma after bevacizumab treatment. The two
panels below the control one show what happens after bevacizumab has been administered after 600 time steps without assuming wheth
the main effect would be a normalization of the angiogenic vasculature (which would increase Ī±, shown in the second row) or the reduc
of the existing vasculature (which would have a negative effect on Ī±, shown in the third row).
changes that we see in glioblastoma patients after failure of
bevacizumab (a monoclonal antibody to VEGF-Ī±).
The recapitulation of known behaviors allows some
measure of conļ¬dence in our model and gives some credence
to predictions that the model can make. Now we can begin to
make observations about the mechanisms driving the behaviors
that were, otherwise, obscured by the biological complexity.
A recurring theme observed in the time-dependent behavior
of our model suggests an underlying mechanism driven by
interactions between different phenotypes. Speciļ¬cally, the
emergence of the invasive phenotypes is always preceded
by a rise in the glycolytic fraction. This rise in the
glycolytic fraction is preceded by an overgrowth of AG cells.
cells grow into a viable proportion, the damage that they
to the local environment with their excessive acid product
begins to promote the beneļ¬t of cells that can move to a n
place (INV). We see this sequence reproduced in nearly
areas of the parameter space, and certainly in all the areas
are relevant to glioma. Further, these results agree nic
with earlier work done by this group suggesting that
glycolytic phenotype is necessary to bring about the emerge
of invasion [18].
In addition to this sequence, there was an interest
dynamic that emerged in some areas of the parameter spa
Figure 5 shows an example of two types of oscillatory behav
that our model can produce. Even though neither manag
38. We use a suite of mathematical and computational
models to bridge a range of spatial and temporal scales.
TIME/SPATIAL SCALE
CELLULAR DETAIL
Evolutionary
Game Theory
Reaction
Diffusion Models
Hybrid Cellular
Automata
Cellular Potts
Model
Immersed
Boundary Model
Hybrid Cellular
Automata
Non-spatial
continuum
Reaction
Diffusion
Network
Theory
39. Symmetric Division Rate
and live in a ācontinuousā milieu described completely by
the experimenter
end result is a model that looks complicated, but is entirely
described by a minimum of parameters - allowing for
emergent phenomena
and the subtype driven by PDGF overexpression. For NF1-driven
cancers, we investigated bi-allelic loss of NF1 and a dominant
negative mutation of TP53 as the necessary driver mutations that
must be accumulated in a single cell to initiate tumorigenesis. For
PDGF-driven cancers, the necessary driving alterations are those
leading to PDGF overexpression and bi-allelic loss of INK4A/ARF.
We did not include the accumulation of passenger mutations in
this model since those alterations, by definition, do not influence
of cells carrying alterations in
similarly leads to increased pro
on the background of either T
INK4A/ARF2/2
NF12/2
cells
fitness RARF 6RNF1,mut and div
In contrast, cells mutated in NF
a fitness detriment, RNF1,wt0.
cell divisions beyond the norm
Figure 1. A mathematical model of the cell of origin of PDGF- and NF1-driven gliomas. Initially, th
cells (blue) and 2z+1
21 wild-type transit-amplifying non-self-renewing (TA) cells (purple). At each time ste
probability a, the SR cell divides symmetrically and one daughter cell replaces another randomly chosen SR
divides asymmetrically and one daughter cell remains a SR cell while the other daughter cell becomes comm
This new TA cell divides symmetrically z times to give rise to successively more differentiated cells (progres
becoming terminally differentiated. This restriction of the stochastic process ensures that the total number of
homeostatic conditions in the healthy brain. In the figure, the darkening purple gradations refer to successively
clarify a single time step of the stochastic process. We investigate the dynamics of only one cell cluster since the
given by the probability per cluster times the number of clusters; hence, a consideration of all clusters does n
cell of origin of brain cancer.
doi:10.1371/journal.pone.0024454.g001
Rounds of Transient
Ampliļ¬cation
Vascular Density
0.01 0.05 0.1
!!!!! !! !!
!!
! !!!!
! !!!!! ! !!!!!! ! !!!!!! ! !!!!!!!
41. 1 5 10 15 20
0
0.5
1
1.5
2
2.5
x 10
5
Divisions per progenitor cell
Cells
s/a 0.1
s/a 0.3
s/a 0.5
1 5 10 15 20
0
0.5
1
1.5
2
x 10
5
Divisions per progenitor cell
s/a 0.1
s/a 0.3
s/a 0.5
1 5 10 15 20
0
0.5
1
1.5
2
2.5
x 10
5
Divisions per progenitor cell
Cells
s/a 0.1
s/a 0.3
s/a 0.5
Vascular Density
Quantifying the unmeasurable
0.01 0.05 0.1
Background:
Metastasis is a highly lethal and poorly understood process that
accounts for the majority cancer deaths
42. We use a suite of mathematical and computational
models to bridge a range of spatial and temporal scales.
TIME/SPATIAL SCALE
CELLULAR DETAIL
Evolutionary
Game Theory
Reaction
Diffusion Models
Hybrid Cellular
Automata
Cellular Potts
Model
Immersed
Boundary Model
Hybrid Cellular
Automata
Non-spatial
continuum
Reaction
Diffusion
Network
Theory
43. 90% of cancer death is from metastatic disease
Yet from the clinicians perspective, metastasis is a binary
event - the least understood process
48. The cutoff frequency .[o is then defined as
1
./o= ~ (17)
Values afro for each segment are listed in Table 1.
5 Computational procedure
A digital computer program was written in FOR-
TRAN to operate on the branching configuration
multiple branching
parallel. Transmiss
node calculated fr
backward towards
pedance of the wh
final result is a com
ching configuration
and transmission p
every node. Hence
ejection waveform
flow waveforms m
53
52/~ 55
51~5136 3~
~7 7i ~4 the branching struc
0s 6o flow throughout th
---r-~ pheral resistance v57 35 47
~564~)]~0__.~33]1~ sistances and visco
The input data t
dimensions and
o~4' _ . ?2
42 i!/6; 2,1 ,e sS/.~ 9
8~8~70 15 49 61, ,, 3, ,, o2 :,, I
, }1 3200[ !/
.o, ,,oo,!,
,o8 ' ~'~, ,03 ~q
~o9 10cm ! ~L
' I 800
pH} c 0
113
,,8 y ' , , s
12it 125
humanarterialtree
Fig. 1 Schematic representation of the human arterial tree
with all lengths drawn to scale. Segment numbers
correspond to arteries listed in Table l
2
r 1-0
.
= -1.ot i
Fig. 2 Input impedanc
pedance in each
simultaneous re
ascending aorta
culatedfrom mo
Medical Biological Engineering Computing November
Jacob Scott, Maciunas STEMM Keynote 2010
49. Simple
Ā experiment
Ā and
Ā ODE
Ā model
Ā
Ā to
Ā
begin
Ā a
Ā conversa:on
Can
Ā likely
Ā measure
Ā f(t)
Ā in
Ā a
Ā mouse
Ā model
Ā by
Ā
injec:on
Ā a
Ā bolus
Ā of
Ā tumor
Ā cells
Ā into
Ā a
Ā tail
Ā
vein
Ā and
Ā measuring
Ā CTCs
Ā at
Ā several
Ā :me
Ā
points
tumor
Other
Ā organ
ā¢C
Ā is
Ā number
Ā of
Ā CTCs
ā¢Alpha
Ā and
Ā beta
Ā are
Ā constants
ā¢T(t)
Ā is
Ā a
Ā func:on
Ā describing
Ā tumor
Ā size
ā¢z(t)
Ā is
Ā rate
Ā of
Ā tumor
Ā cell
Ā intravasa:on
Ā
āshedding
Ā rateā
ā¢f(t)
Ā is
Ā the
Ā rate
Ā of
Ā ļ¬ltra:on
Ā or
Ā CTC
Ā arrest
Jacob Scott, Maciunas STEMM Keynote 2010
52. !#$%'#()*'+,
-+'.#
!./*+
0,
-1'((*+'#(2+3%,',*
-3#*
Ī²
Ī·
Ī³
Unifying metastasis ā integrating
intravasation, circulation and
end-organ colonization
Jacob Scott1,2
, Peter Kuhn3
and Alexander R. A. Anderson1
!#$%'$()(*+'+,$($+'-,./.01'/(23,'+#($-$(-3+(+,/+2($-+(4+#5%+4+,$(.6('1%'5/$1,0(
$54.5%('+//#(7898#:(1,(;$1+,$#(-3+(#;5%%+2(1,$+%+#$(1,($-+('1%'5/$.%(;-#+(.6(4+$#$#1#=(
9+'-,15+#($-$(2.(,.$(#./+/(%+/(.,((/..2(#4;/+(//.?(#5#$,$1/(1./.01'/(1,$+%%.0$1.,(
+.,2(#14;/('.5,$1,0(898#=
for
gy,
A.
In patients with advanced primary cancer, circulating
tumour cells (CTCs)1
can be found throughout the entire
vascular system2
. When and where these CTCs form
metastasis is not fully understood, and is currently the
subject of intensive biological study. Pagetās well-known
seedāsoil hypothesis3
suggests that the āsoilā (the site of
a metastasis) is as important as the āseedā (the metastatic
cells) in the determination of successful metastasis. The
mechanism by which seeds are disseminated to specific
soil has, to date, been a āknown unknownā. We think that
it is during this poorly understood phase of metastasis
that we stand to answer important questions4
.
We hypothesize that the rich variety of possible meta-
static disease patterns not only stems from the physical
aspects of the circulation but also from CTC hetero-
geneity (FIG. 1). These seeds represent many different
populations that are derived from a diverse population
of competing phenotypes within the primary tumour5
.
Because such seeds need to pass through a system of
physical and biological filters in the form of specific
organs, the circulatory phase of metastasis could be
modelled as a complex deterministic filter. In theory,
until the evolution of a suitable seed, any number of
CTCs could flow through the circulation and arrest
at end organs without metastases forming. As tumour
heterogeneity is thought to expand as the tumour pro-
gresses, it follows that at some point a seed will come
into existence that is suited to a specific soil within that
patientās body. If this seed is to propagate it must find
its soil, a process that we hypothesize is governed by
solvable physical rules that relate to the dynamics of
do not fit a model that is defined only by physical flow
and filtration.
To begin the process of physical interrogation, we
propose a model that represents the human circulatory
system as a directed and weighted network, with nodes
representing organs and edges representing arteries and
veins.The novelty is only fully realized when combined
withaheterogeneousCTCpopulation(drivenbyprimary
tumour heterogeneity) modulated by the complex organ
filter system (with physiologically relevant connections)
under dynamic flow. Four important biological processes
emerge from this representation. First, the shedding rate,
which is defined as the rate at which the tumour sheds
CTCs into the vasculature. Second, CTC heterogeneity,
which is defined as the distribution of CTC phenotypes
present in the circulation. Third, the filtration fraction,
which is defined as the proportion (and type) of CTCs
that arrest in a given organ. Fourth, the clearance rate,
which is defined as the rate at which cancer cells are
cleared from the blood and/or organ after arrest. Each of
these biological processes is probably disease- and even
patient-specific, and each is extremely poorly understood.
Using this representation to motivate the develop-
ment of a mathematical model we can define both the
concentration of CTCs and their phenotypic distribu-
tion at any given point in the network, as well as organ-
specific filtration values. To parameterize this model,
characterization and enumeration of CTCs taken from
a single patient at different time points and from differ-
ent points in this network will need to be undertaken.
A complete understanding of the model will also pro-
Unifying metastasis ā int
intravasation, circulation
end-organ colonization
Jacob Scott1,2
, Peter Kuhn3
and Alexander R. A. Anders
!#$%'$()(*+'+,$($+'-,./.01'/(23,'+#($-$(-3+(+,/+2($
$54.5%('+//#(7898#:(1,(;$1+,$#(-3+(#;5%%+2(1,$+%+#$(1,($-+('1%
8@A
Nature Reviews Cancer | AOP, published online 24 May 2012; doi:10.1038/nrc3287
54. Jacob Scott, Maciunas STEMM Keynote 2010
Matrices are important - pay attention in AMH!!
55. āWhereas a good simulation should
include as much as possible, a good
model should include as little as possible.ā
Jacob Scott, Maciunas STEMM Keynote 2010
57. Brain
Liver
Gut
Bone
Venous Arterial
Portal System
CTCļ¬ow
Lung
Breast
Primary Seeding
Primary
Tumor
(a) Primary Seeding cartoon
Brain
Liver
Gut
Bone
Venous Arterial
Portal System
CTCļ¬ow
Lung
Breast
Primary
Tumor
Secondary
Tumor
Secondary
Tumor
Secondary Seeding
(b) Secondary Seeding cartoon
A
Time (cell cycles)
Logtumourmass B
Removal rate Ī»
Returnprobabilityp
growthacceleration(logscale)
primary
seeding
secondary
seeding
Figure 2: Simulating the dynamics of primary seeding.(A) shows the total tumour b
for three diļ¬erent conditions where the removal rate was ļ¬xed at Ī» = 10ā5 and return proba
was taken to be p = 10ā2,10ā3 and 10ā4 respectively. (B) illustrates the model dynamics
the parameters Ī» and p are varied systematically, and shows that accelerated tumour growth
, 20130011, published 20 February 2013102013J. R. Soc. Interface
Jacob G. Scott, David Basanta, Alexander R. A. Anderson and Philip Gerlee
growth
secondary metastatic deposits as drivers of primary tumour
A mathematical model of tumour self-seeding reveals
Open Access
58. science society
B
iology has long been the stepchild
of the natural sciences. Compared
with mathematical proofs, physical
formulae and the molecules of chemistry,
biology, like life itself, has often seemed
unquantifiable, unpredictable and messy.
Yet, scientists have striven gallantly to pin
biology down through the application of the
of inspiration for mathematicians. āIn my
40 plus years of research, I have found that
problems in biomathematics almost always
uncover unexplored and undeveloped areas
of mathematics,ā he said. āThese are areas
that mathematicians have not even thought
about exploring. New mathematics.ā
involves events a
gene expression o
take place in nano
nisms or body-wi
minutes, hours o
between people
tions that last mon
understand these s
different layers an
Jost points out, ha
mathematical biolo
T
he applicatio
logy itself i
back at least
on the inheritanc
nineteenth centur
the theory of Men
foundation of mod
ally reproducing o
Biology is the new physics
The increasing use of mathematics in biology is both inspiring
research in mathematics and creating new career options for
mathematical biologists
Philip Hunter
EMBO reports VOL 11 | NO 5 | 2010350
āFor many years the inspiration for
innovation in applied mathematics has
come from physics, but in my opinion,
in this century it will come from the bio-
logical sciences, broadly defined,ā Mackey
explained, adding that this switch has been
taking place slowly over several decades.
While physics has stagnated, waiting for
new theoretical insights to make progress
against fundamental problems such as
quantum gravity, Mackey argued, theoreti-
cal biology has emerged as a new source
complexes;
able to accou
tle difference
infection am
ous approac
growing use
biological an
capable of a
the systems u
of a protein,
essence, inf
geometry wi
changing, co
Other tech
information
tions betwee
a huge ran
The human
continue to the extent that it
might even become the main
driving force behind innovation
and development in mathematics